Cargando…
Preclinical In Vivo Evaluation of the Safety of a Multi-shRNA-based Gene Therapy Against HIV-1
Highly active antiretroviral therapy (HAART) has significantly improved the quality of life and the life expectancy of HIV-infected individuals. Still, drug-induced side effects and emergence of drug-resistant viral variants remain important issues that justify the exploration of alternative therape...
Autores principales: | Centlivre, Mireille, Legrand, Nicolas, Klamer, Sofieke, Liu, Ying Poi, Eije, Karin Jasmijn von, Bohne, Martino, Rijnstra, Esther Siteur-van, Weijer, Kees, Blom, Bianca, Voermans, Carlijn, Spits, Hergen, Berkhout, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808742/ https://www.ncbi.nlm.nih.gov/pubmed/24002730 http://dx.doi.org/10.1038/mtna.2013.48 |
Ejemplares similares
-
Preclinical test of a lentivirus-mediated RNAi gene therapy against HIV-AIDS in the humanized mouse model
por: Centlivre, Mireille, et al.
Publicado: (2011) -
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
por: Brake, Olivier ter, et al.
Publicado: (2008) -
The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment
por: Klamer, Sofieke, et al.
Publicado: (2014) -
Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice
por: Espíndola, Otávio de Melo, et al.
Publicado: (2021) -
Downregulation of CD1 Marks Acquisition of Functional Maturation of Human Thymocytes and Defines a Control Point in Late Stages of Human T Cell Development
por: Res, Pieter, et al.
Publicado: (1997)